Background: Chronic liver disease (CLD) remains a major global health challenge, encompassing a wide range of etiologies and presenting with significant morbidity and mortality. Despite advances in treatment strategies, severe chronic liver disease requires a multidisciplinary approach to ensure optimal outcomes. Objective: This study aimed to evaluate the clinical, biochemical, and histological remission of severe chronic liver disease and analyse the effectiveness of various treatment modalities in predicting early prognosis. Methods: A cross-sectional study was conducted at Poonch Medical College from January 2023 to January 2024, involving 164 participants diagnosed with severe chronic liver disease. Comprehensive clinical, biochemical, and histological data were collected, including fibrosis, steatosis, inflammation, and necrosis assessments. Treatment modalities included pharmacological interventions, lifestyle modifications, and advanced interventional procedures. Statistical analyses were performed to identify significant correlations between treatment adherence, histological findings, and clinical outcomes. Results: Middle-aged individuals and males constituted the majority of the cohort, with nonalcoholic fatty liver disease (NAFLD) emerging as the most prevalent aetiology. Elevated ALT levels, advanced fibrosis (40%), and significant correlations between histological parameters and MELD scores were observed. Pharmacological interventions were the most utilised treatment modality (61%), while high adherence rates (≥80%) were strongly associated with improved biochemical and clinical outcomes. Lifestyle interventions demonstrated effective NAFLD management; interventional procedures were reserved for severe cases. Adverse effects were reported in 30.5% of participants, underscoring the need for careful monitoring. Conclusion: The findings emphasise the importance of early diagnosis, histological assessments, and integrated treatment approaches in managing severe chronic liver disease. High treatment adherence and individualised care plans significantly improve outcomes. Future research should focus on longitudinal studies to validate these findings and explore long-term remission and prognosis.